Measles Seroprevalence and Vaccine Responses in HIV-Infected Adolescents and Adults: A Systematic Review

HIV / AIDSViral Infections, Non-HIV

Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I

Infect Dis Ther.

Crum-Cianflone NF, Sullivan E

doi: 10.1007/s40121-017-0166-x.

Viral Infections, Non-HIV

Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis

J Infect Dis.

Ng TWY, Cowling BJ, Gao HZ, Thompson MG

doi: 10.1093/infdis/jiy720.

Bacterial InfectionsViral Infections, Non-HIV

Does BCG Vaccination Protect Against Non-Tuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis

J Infect Dis.

Zimmermann P, Finn A, Curtis N

doi: 10.1093/infdis/jiy207.

Further Publications AnesthesiologyFurther Publications PainFurther Publications Infectiology

MenACWY-CRM conjugate vaccine booster dose given 4-6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults

Vaccine.

Tipton M, Daly W, Senders S, Block SL, Lattanzi M, Mzolo T, Barbi S, Pellegrini M, Keshavan P

doi: 10.1016/j.vaccine.2019.08.065.

Viral Infections, Non-HIV

Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: A systematic review

Vaccine.

Walker EJ, MacDonald NE, Islam N, Le Saux N, Top KA, Fell DB

doi: 10.1016/j.vaccine.2019.02.031.

Viral Infections, Non-HIV

Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis

Lancet Infect Dis.

Flacco ME, Manzoli L, Rosso A, Marzuillo C, Bergamini M, Stefanati A, Cultrera R, Villari P, Ricciardi W, Ioannidis JPA, Contopoulos-Ioannidis DG

doi: 10.1016/

HIV / AIDSViral Infections, Non-HIV

Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis

Lancet Infect Dis.

Lin C, Franceschi S, Clifford GM

doi: 10.1016/

Viral Infections, Non-HIV

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Vaccine.

Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, Watson-Jones D

doi: 10.1016/j.vaccine.2019.12.017.

Bacterial Infections

Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP

Vaccine.

Decker MD, Greenberg DP, Johnson DR, Pool V

doi: 10.1016/j.vaccine.

Related content

Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I

Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis

Does BCG Vaccination Protect Against Non-Tuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis

MenACWY-CRM conjugate vaccine booster dose given 4-6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults

Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: A systematic review

Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis

Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP

MenACWY-CRM conjugate vaccine booster dose given 4-6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults